NYMC Faculty Publications
Can Charcoal Improve Outcomes in COVID-19 Infections?
DOI
10.1016/j.mehy.2020.110176
Journal Title
Medical Hypotheses
First Page
110176
Last Page
110176
Document Type
Article
Publication Date
11-1-2020
Department
Medicine
Abstract
COVID-19 infection causes considerable morbidity and mortality, especially to those who are aged, have impaired renal function and are obese. We propose to examine the potential utility of oral activated charcoal with the hypothesis that such treatment would lower absorption of microbiome derived toxins and ameliorate systemic oxidant stress and inflammation.
Recommended Citation
Khitan, Z. J., Khawaja, I., Mufson, M. A., Sanabria, J. R., Abraham, N. G., Peterson, S. J., Sundaram, U., & Shapiro, J. (2020). Can Charcoal Improve Outcomes in COVID-19 Infections?. Medical Hypotheses, 144, 110176-110176. https://doi.org/10.1016/j.mehy.2020.110176
COinS
